Does pre-treatment with lamivudine prime for adefovir resistance of hepatitis B virus infection?
Sirma
Hüseyin
H
Funk
Anneke
A
Gerlich
Wolfram
W
Schildgen
Oliver
O
D000225:Adenine / Q000031:analogs & derivatives* / Q000494:pharmacology; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000494:pharmacology*; D024882:Drug Resistance, Viral; D006515:Hepatitis B virus / Q000187:drug effects / Q000235:genetics; D019694:Hepatitis B, Chronic / Q000188:drug therapy* / Q000821:virology; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use*; D063065:Organophosphonates / Q000494:pharmacology*
D019380:Anti-HIV Agents; D000998:Antiviral Agents; D063065:Organophosphonates; D019259:Lamivudine; C053001:adefovir; D000225:Adenine